Sustained Effect of Delayed-Release Dimethyl Fumarate in Newly Diagnosed Patients with Relapsing–Remitting Multiple Sclerosis: 6-Year Interim Results From an Extension of the DEFINE and CONFIRM Studies

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2193-6536

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Sustained Effect of Delayed-Release Dimethyl Fumarate in Newly Diagnosed Patients with Relapsing–Remitting Multiple Sclerosis: 6-Year Interim Results From an Extension of the DEFINE and CONFIRM Studies ; volume:5 ; number:1 ; day:1 ; month:3 ; year:2016 ; pages:45-57 ; date:6.2016
Neurology and Therapy ; 5, Heft 1 (1.3.2016), 45-57, 6.2016

Creator: Gold, Ralf

Contributor: Giovannoni, Gavin
Phillips, J. Theodore
Fox, Robert J.
Zhang, Annie
Marantz, Jing L.
SpringerLink (Online service)

DOI: 10.1007/s40120-016-0042-8

URN: urn:nbn:de:1111-201606258033

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 11:02 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Gold, Ralf
Giovannoni, Gavin
Phillips, J. Theodore
Fox, Robert J.
Zhang, Annie
Marantz, Jing L.
SpringerLink (Online service)

Other Objects (12)

Relapsing/remitting type 1 diabetes

Comparative analysis of dimethyl fumarate and fingolimod in relapsing–remitting multiple sclerosis

Efficacy of Dimethyl Fumarate in Young Adults with Relapsing-Remitting Multiple Sclerosis: Analysis of the DEFINE, CONFIRM, and ENDORSE Studies

Persistence with dimethyl fumarate in relapsing-remitting multiple sclerosis: a population-based cohort study

Endocarditis following ocrelizumab in relapsing-remitting MS

Postural Control in Relapsing-Remitting Multiple Sclerosis

Relapsing–remitting painful ophthalmoplegia due to orbital myositis

Abnormal multisensory integration in relapsing–remitting multiple sclerosis

Therapeutic efficacy of dimethyl fumarate in relapsing-remitting multiple sclerosis associates with ROS pathway in monocytes

Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis

Longitudinal cortical network reorganization in early relapsing–remitting multiple sclerosis

Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis

Relapsing/remitting type 1 diabetes

Comparative analysis of dimethyl fumarate and fingolimod in relapsing–remitting multiple sclerosis

Efficacy of Dimethyl Fumarate in Young Adults with Relapsing-Remitting Multiple Sclerosis: Analysis of the DEFINE, CONFIRM, and ENDORSE Studies

Persistence with dimethyl fumarate in relapsing-remitting multiple sclerosis: a population-based cohort study

Endocarditis following ocrelizumab in relapsing-remitting MS

Postural Control in Relapsing-Remitting Multiple Sclerosis

Relapsing–remitting painful ophthalmoplegia due to orbital myositis

Abnormal multisensory integration in relapsing–remitting multiple sclerosis

Therapeutic efficacy of dimethyl fumarate in relapsing-remitting multiple sclerosis associates with ROS pathway in monocytes

Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis

Longitudinal cortical network reorganization in early relapsing–remitting multiple sclerosis

Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis

Relapsing/remitting type 1 diabetes

Comparative analysis of dimethyl fumarate and fingolimod in relapsing–remitting multiple sclerosis

Efficacy of Dimethyl Fumarate in Young Adults with Relapsing-Remitting Multiple Sclerosis: Analysis of the DEFINE, CONFIRM, and ENDORSE Studies

Persistence with dimethyl fumarate in relapsing-remitting multiple sclerosis: a population-based cohort study

Endocarditis following ocrelizumab in relapsing-remitting MS

Postural Control in Relapsing-Remitting Multiple Sclerosis

Relapsing–remitting painful ophthalmoplegia due to orbital myositis

Abnormal multisensory integration in relapsing–remitting multiple sclerosis

Therapeutic efficacy of dimethyl fumarate in relapsing-remitting multiple sclerosis associates with ROS pathway in monocytes

Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis

Longitudinal cortical network reorganization in early relapsing–remitting multiple sclerosis

Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Sustained Effect of Delayed-Release Dimethyl Fumarate in Newly Diagnosed Patients with Relapsing–Remitting Multiple Sclerosis: 6-Year Interim Results From an Extension of the DEFINE and CONFIRM Studies

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Relapsing/remitting type 1 diabetes

Comparative analysis of dimethyl fumarate and fingolimod in relapsing–remitting multiple sclerosis

Efficacy of Dimethyl Fumarate in Young Adults with Relapsing-Remitting Multiple Sclerosis: Analysis of the DEFINE, CONFIRM, and ENDORSE Studies

Persistence with dimethyl fumarate in relapsing-remitting multiple sclerosis: a population-based cohort study

Endocarditis following ocrelizumab in relapsing-remitting MS

Postural Control in Relapsing-Remitting Multiple Sclerosis

Relapsing–remitting painful ophthalmoplegia due to orbital myositis

Abnormal multisensory integration in relapsing–remitting multiple sclerosis

Therapeutic efficacy of dimethyl fumarate in relapsing-remitting multiple sclerosis associates with ROS pathway in monocytes

Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis

Longitudinal cortical network reorganization in early relapsing–remitting multiple sclerosis

Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis

Relapsing/remitting type 1 diabetes

Comparative analysis of dimethyl fumarate and fingolimod in relapsing–remitting multiple sclerosis

Efficacy of Dimethyl Fumarate in Young Adults with Relapsing-Remitting Multiple Sclerosis: Analysis of the DEFINE, CONFIRM, and ENDORSE Studies

Persistence with dimethyl fumarate in relapsing-remitting multiple sclerosis: a population-based cohort study

Endocarditis following ocrelizumab in relapsing-remitting MS

Postural Control in Relapsing-Remitting Multiple Sclerosis

Relapsing–remitting painful ophthalmoplegia due to orbital myositis

Abnormal multisensory integration in relapsing–remitting multiple sclerosis

Therapeutic efficacy of dimethyl fumarate in relapsing-remitting multiple sclerosis associates with ROS pathway in monocytes

Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis

Longitudinal cortical network reorganization in early relapsing–remitting multiple sclerosis

Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis

Relapsing/remitting type 1 diabetes

Comparative analysis of dimethyl fumarate and fingolimod in relapsing–remitting multiple sclerosis

Efficacy of Dimethyl Fumarate in Young Adults with Relapsing-Remitting Multiple Sclerosis: Analysis of the DEFINE, CONFIRM, and ENDORSE Studies

Persistence with dimethyl fumarate in relapsing-remitting multiple sclerosis: a population-based cohort study

Endocarditis following ocrelizumab in relapsing-remitting MS

Postural Control in Relapsing-Remitting Multiple Sclerosis

Relapsing–remitting painful ophthalmoplegia due to orbital myositis

Abnormal multisensory integration in relapsing–remitting multiple sclerosis

Therapeutic efficacy of dimethyl fumarate in relapsing-remitting multiple sclerosis associates with ROS pathway in monocytes

Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis

Longitudinal cortical network reorganization in early relapsing–remitting multiple sclerosis

Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis

Related objects

Reset password